SlideShare a Scribd company logo
1 of 21
COPD
DR C B DHANRAJ
EPIDEMIOLOGY
• As of 2015, COPD affected about 174.5 million people (2.4% of the
global population).[7]
• It typically occurs in males and females over the age of 35–40.[1][3] In
2019 it caused 3.2 million deaths, 80% occurring in lower and middle
income countries,[3] up from 2.4 million deaths in 1990.[22][23]
• The number of deaths is projected to increase further because of
continued exposure to risk factors and an aging population.
• Chronic obstructive pulmonary disease (COPD) is a type of
progressive lung disease characterized by long-term respiratory
symptoms and airflow limitation.[8]
• The main symptoms of COPD include shortness of breath and
a cough, which may or may not produce mucus.[4] COPD progressively
worsens, with everyday activities such as walking or dressing
becoming difficult.[3]
• While COPD is incurable, it is preventable and treatable.
• Emphysema is defined as enlarged airspaces (alveoli)
whose walls have broken down resulting in permanent damage to
the lung tissue. Chronic bronchitis is defined as a productive cough
that is present for at least three months each year for two years. Both
of these conditions can exist without airflow limitation when they are
not classed as COPD.
• Many definitions of COPD in the past included emphysema and
chronic bronchitis, but these have never been included in GOLD
report definitions.[8] Emphysema and chronic bronchitis remain the
predominant phenotypes of COPD but there is often overlap between
them and a number of other phenotypes have also been
described.[9][13] .[12
• COPD and asthma may coexist and converge in some
individuals.[14] COPD is associated with low-grade systemic
inflammation.[15]
• The most common cause of COPD is tobacco smoking.[16] Other risk
factors include indoor and outdoor air pollution including dust,
exposure to occupational irritants such as dust from grains, cadmium
dust or fumes, and genetics, such as alpha-1 antitrypsin deficiency
• In developing countries, common sources of indoor air pollution are
the use of coal and biomass such as wood and dry dung as fuel
for cooking and heating.[18][12] The diagnosis is based on poor airflow
as measured by spirometry.[4]
• Most cases of COPD can be prevented by reducing exposure to risk
factors such as smoking and indoor and outdoor pollutants.[19] While
treatment can slow worsening, there is no conclusive evidence that
any medications can change the long-term decline in lung
function.[6] COPD treatments include smoking
cessation, vaccinations, pulmonary
rehabilitation, inhaled bronchodilators and corticosteroids.[6]
Exacerbations
An acute exacerbation is a sudden worsening of signs and symptoms that lasts for
several days. The key symptom is increased breathlessness, other more
pronounced symptoms are of excessive mucus, increased cough and wheeze. A
commonly found sign is air trapping giving a difficulty in complete exhalation.[30] The
usual cause of an exacerbation is a viral infection, most often the common
cold.[12] The common cold is usually associated with the winter months but can
occur at any time.[31] Other respiratory infections may be bacterial or in combination
sometimes secondary to a viral infection.[32] The most common bacterial infection is
caused by Haemophilus influenzae.[33] Other risks include exposure to tobacco
smoke (active and passive) and environmental pollutants – both indoor and
outdoor.[34] During the COVID-19 pandemic, hospital admissions for COPD
exacerbations sharply decreased which may be attributable to reduction of
emissions and cleaner air.[35] There has also been a marked decrease in the
number of cold and flu infections during this time.[36]
Smoke from wildfires is proving an increasing risk in many parts
of the world and government agencies have published protective
advice on their websites. In the US the EPA advises that the use
of dust masks do not give protection from the fine particles
in wildfires and instead advise the use of well-fitting particulate
masks.[37] This same advice is offered in Canada to the effects of
their forest fires.[38] Bushfires in Australia add to the high risk
factors for COPD and its worsening for farmers.[39]
The number of exacerbations is not seen to relate to any stage of
the disease; those with two or more a year are classed
as frequent exacerbators and these lead to a worsening in the
disease progression.[30] Frailty in ageing increases exacerbations
and hospitalization.[40]
Acute exacerbations in COPD are often unexplained and thought
to have many causes other than infections. A study has
emphasized the possibility of a pulmonary embolism as
sometimes being responsible in these cases. Signs can
include pleuritic chest pain and heart failure without signs of
infection. Such emboli could respond to anticoagulants.[41]
COPD.pptx
COPD.pptx
COPD.pptx
COPD.pptx
COPD.pptx
COPD.pptx

More Related Content

Similar to COPD.pptx

ReFlections Spring 2015
ReFlections Spring 2015ReFlections Spring 2015
ReFlections Spring 2015
H Henly
 
Chronic Obstructive Disorder
Chronic Obstructive DisorderChronic Obstructive Disorder
Chronic Obstructive Disorder
ninachrisanta
 

Similar to COPD.pptx (20)

AIR POLLUTION AND HUMAN DISEASES.pptx
AIR POLLUTION AND HUMAN DISEASES.pptxAIR POLLUTION AND HUMAN DISEASES.pptx
AIR POLLUTION AND HUMAN DISEASES.pptx
 
COPD
COPDCOPD
COPD
 
Crea europe-covid-impacts
Crea europe-covid-impactsCrea europe-covid-impacts
Crea europe-covid-impacts
 
Effects of Smoking
Effects of SmokingEffects of Smoking
Effects of Smoking
 
COPD INTRODUCTION.pptx
COPD INTRODUCTION.pptxCOPD INTRODUCTION.pptx
COPD INTRODUCTION.pptx
 
ReFlections Spring 2015
ReFlections Spring 2015ReFlections Spring 2015
ReFlections Spring 2015
 
Chronic Obstructive Disorder
Chronic Obstructive DisorderChronic Obstructive Disorder
Chronic Obstructive Disorder
 
Gold pocket 2015_feb18
Gold pocket 2015_feb18Gold pocket 2015_feb18
Gold pocket 2015_feb18
 
Gold pocket 2015_feb18
Gold pocket 2015_feb18Gold pocket 2015_feb18
Gold pocket 2015_feb18
 
COPD definition, phenotypes, epidemiology
COPD definition, phenotypes, epidemiologyCOPD definition, phenotypes, epidemiology
COPD definition, phenotypes, epidemiology
 
Air pollution and cardiovascular disease
Air pollution and cardiovascular diseaseAir pollution and cardiovascular disease
Air pollution and cardiovascular disease
 
heard diseases in air pollution
heard diseases in air pollutionheard diseases in air pollution
heard diseases in air pollution
 
Emphysema disease
Emphysema diseaseEmphysema disease
Emphysema disease
 
Air Pollution and Cardiovascular health.pptx
Air Pollution and Cardiovascular health.pptxAir Pollution and Cardiovascular health.pptx
Air Pollution and Cardiovascular health.pptx
 
Gold guideline ppt 2019 final shivaom
Gold guideline ppt 2019 final shivaomGold guideline ppt 2019 final shivaom
Gold guideline ppt 2019 final shivaom
 
Air pollutant by Dr. Neel Chugh
Air pollutant by Dr. Neel ChughAir pollutant by Dr. Neel Chugh
Air pollutant by Dr. Neel Chugh
 
Pollution Effects On Health
Pollution Effects On HealthPollution Effects On Health
Pollution Effects On Health
 
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease
 
COPD Teaching Slides for UGs
COPD Teaching Slides for UGsCOPD Teaching Slides for UGs
COPD Teaching Slides for UGs
 
Copd hha a_pacheco
Copd hha a_pachecoCopd hha a_pacheco
Copd hha a_pacheco
 

More from DhanrajCanchiBhoopal (11)

Cricket World Cup.pptx
Cricket World Cup.pptxCricket World Cup.pptx
Cricket World Cup.pptx
 
plasma cell disorder.pptx
plasma cell disorder.pptxplasma cell disorder.pptx
plasma cell disorder.pptx
 
Sneha Joshi.pptx
Sneha Joshi.pptxSneha Joshi.pptx
Sneha Joshi.pptx
 
mohit.pptx
mohit.pptxmohit.pptx
mohit.pptx
 
swasa.pptx
swasa.pptxswasa.pptx
swasa.pptx
 
Depression.pptx
Depression.pptxDepression.pptx
Depression.pptx
 
Paridhi.pptx
Paridhi.pptxParidhi.pptx
Paridhi.pptx
 
hospital management.pptx
hospital management.pptxhospital management.pptx
hospital management.pptx
 
CANCER (1).pptx
CANCER (1).pptxCANCER (1).pptx
CANCER (1).pptx
 
vandana ppt on cml.pptx
vandana ppt on cml.pptxvandana ppt on cml.pptx
vandana ppt on cml.pptx
 
TB CASE STUDY.pptx
TB CASE STUDY.pptxTB CASE STUDY.pptx
TB CASE STUDY.pptx
 

Recently uploaded

VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
JRRolfNeuqelet
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 

Recently uploaded (20)

TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
 
Quality control tests of suppository ...
Quality control tests  of suppository ...Quality control tests  of suppository ...
Quality control tests of suppository ...
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 

COPD.pptx

  • 1. COPD DR C B DHANRAJ
  • 2. EPIDEMIOLOGY • As of 2015, COPD affected about 174.5 million people (2.4% of the global population).[7] • It typically occurs in males and females over the age of 35–40.[1][3] In 2019 it caused 3.2 million deaths, 80% occurring in lower and middle income countries,[3] up from 2.4 million deaths in 1990.[22][23] • The number of deaths is projected to increase further because of continued exposure to risk factors and an aging population.
  • 3. • Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation.[8] • The main symptoms of COPD include shortness of breath and a cough, which may or may not produce mucus.[4] COPD progressively worsens, with everyday activities such as walking or dressing becoming difficult.[3] • While COPD is incurable, it is preventable and treatable.
  • 4. • Emphysema is defined as enlarged airspaces (alveoli) whose walls have broken down resulting in permanent damage to the lung tissue. Chronic bronchitis is defined as a productive cough that is present for at least three months each year for two years. Both of these conditions can exist without airflow limitation when they are not classed as COPD.
  • 5. • Many definitions of COPD in the past included emphysema and chronic bronchitis, but these have never been included in GOLD report definitions.[8] Emphysema and chronic bronchitis remain the predominant phenotypes of COPD but there is often overlap between them and a number of other phenotypes have also been described.[9][13] .[12
  • 6. • COPD and asthma may coexist and converge in some individuals.[14] COPD is associated with low-grade systemic inflammation.[15] • The most common cause of COPD is tobacco smoking.[16] Other risk factors include indoor and outdoor air pollution including dust, exposure to occupational irritants such as dust from grains, cadmium dust or fumes, and genetics, such as alpha-1 antitrypsin deficiency
  • 7. • In developing countries, common sources of indoor air pollution are the use of coal and biomass such as wood and dry dung as fuel for cooking and heating.[18][12] The diagnosis is based on poor airflow as measured by spirometry.[4]
  • 8. • Most cases of COPD can be prevented by reducing exposure to risk factors such as smoking and indoor and outdoor pollutants.[19] While treatment can slow worsening, there is no conclusive evidence that any medications can change the long-term decline in lung function.[6] COPD treatments include smoking cessation, vaccinations, pulmonary rehabilitation, inhaled bronchodilators and corticosteroids.[6]
  • 9.
  • 10.
  • 11.
  • 12. Exacerbations An acute exacerbation is a sudden worsening of signs and symptoms that lasts for several days. The key symptom is increased breathlessness, other more pronounced symptoms are of excessive mucus, increased cough and wheeze. A commonly found sign is air trapping giving a difficulty in complete exhalation.[30] The usual cause of an exacerbation is a viral infection, most often the common cold.[12] The common cold is usually associated with the winter months but can occur at any time.[31] Other respiratory infections may be bacterial or in combination sometimes secondary to a viral infection.[32] The most common bacterial infection is caused by Haemophilus influenzae.[33] Other risks include exposure to tobacco smoke (active and passive) and environmental pollutants – both indoor and outdoor.[34] During the COVID-19 pandemic, hospital admissions for COPD exacerbations sharply decreased which may be attributable to reduction of emissions and cleaner air.[35] There has also been a marked decrease in the number of cold and flu infections during this time.[36]
  • 13.
  • 14. Smoke from wildfires is proving an increasing risk in many parts of the world and government agencies have published protective advice on their websites. In the US the EPA advises that the use of dust masks do not give protection from the fine particles in wildfires and instead advise the use of well-fitting particulate masks.[37] This same advice is offered in Canada to the effects of their forest fires.[38] Bushfires in Australia add to the high risk factors for COPD and its worsening for farmers.[39]
  • 15. The number of exacerbations is not seen to relate to any stage of the disease; those with two or more a year are classed as frequent exacerbators and these lead to a worsening in the disease progression.[30] Frailty in ageing increases exacerbations and hospitalization.[40] Acute exacerbations in COPD are often unexplained and thought to have many causes other than infections. A study has emphasized the possibility of a pulmonary embolism as sometimes being responsible in these cases. Signs can include pleuritic chest pain and heart failure without signs of infection. Such emboli could respond to anticoagulants.[41]